GPI 1485 ( DrugBank: GPI-1485 )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2

6. Parkinson disease

---

Clinical trials : 2,298 /  Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00076492 (ClinicalTrials.gov)	January 2004	23/1/2004	NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485	A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485 in Subjects With Early Untreated Parkinson's Disease	Parkinson Disease	Drug: CoQ10;Drug: GPI 1485	University of Rochester	National Institute of Neurological Disorders and Stroke (NINDS)	Completed	30 Years	N/A	Both	195	Phase 2	United States
2	NCT00209508 (ClinicalTrials.gov)	November 2002	13/9/2005	2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects Of GPI 1485 On [123I]b-CIT/SPECT Scanning And Clinical Efficacy In Symptomatic PD Patients Receiving Dopamine Agonist Therapy.	Parkinson's Disease	Drug: GPI 1485	Eisai Inc.	Symphony Neuro Development Company	Completed	40 Years	80 Years	Both	200	Phase 2	NULL